The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“C3aR, and its endogenous ligands has been implicated previously in obesity[101–105].”
From Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity (2026) · cites this paper as [105]
In the citing paper
“TLQP-21 has emerged as a novel therapeutic target with the potential for treating obesity primarily by modulating lipolysis without apparent adverse cardiovascular effects as assessed by studies in mice and rats [Possenti et al., 2012; Cero et al., 2017; Fargali et al., 2014].”
From Clearance kinetics of the VGF-derived neuropeptide TLQP-21 (2018) · cites this paper as Cero et al., 2017
In the citing paper
“Overall, these results suggest that plasma peptidases degrade the native TLQP-21 to generate multiple smaller fragments that are unlikely to be biologically active [Cero et al., 2017; Petrocchi-Passeri et al., 2015] but rather limit its biological actions.”
From Clearance kinetics of the VGF-derived neuropeptide TLQP-21 (2018) · cites this paper as Cero et al., 2017
In the citing paper
“The pro-lipolytic property of TLQP-21 has been previously reported [Possenti et al, 2012; Cero et al., 2017]”
From Clearance kinetics of the VGF-derived neuropeptide TLQP-21 (2018) · cites this paper as Cero et al., 2017
In the citing paper
“By mutating the Arg21 into Arg21 (R21A peptide) the resulting peptide is inactive [Cero et al., 2014, 2017; Doleen et al., 2017] that still preserves its ability to form α-helix in the presence of the C3aRl [Cero et al., 2014]”
From Clearance kinetics of the VGF-derived neuropeptide TLQP-21 (2018) · cites this paper as Cero et al., 2017
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guh, D. P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C. L., & Anis, A. H. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-88 · Cited by 3,855
Towards a molecular understanding of adaptive thermogenesis
Lowell, B. B., & Spiegelman, B. M. (2000) · Nature · doi:10.1038/35007527 · Cited by 1,630
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective
Virtue, S., & Vidal-Puig, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.006 · Cited by 1,013 · cited 1×
“Importantly, TLQP-21 did not increase liver or quadriceps muscle fat content (Figure S2E,F), thus excluding that mild lipolysis would cause ectopic fat accumulation and associated lypotoxicity [44].”
BackgroundA Creatine-Driven Substrate Cycle Enhances Energy Expenditure and Thermogenesis in Beige Fat
Kazak, L., Chouchani, E. T., Jedrychowski, M. P., Erickson, B. K., Shinoda, K., Cohen, P., Vetrivelan, R., Lu, G. Z., Laznik-Bogoslavski, D., Hasenfuss, S. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.035 · Cited by 787
Research works printed but not linked: 63
- Schwartz, 2000, Central nervous system control of food intake, Nature, 404, 661, 10.1038/35007534 · DOI · Paper page
- Kopelman, 2000, Obesity as a medical problem, Nature, 404, 635, 10.1038/35007508 · DOI · Paper page
- Lönnqvist, 1992, Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells, Journal of Clinical Investigation, 90, 2175, 10.1172/JCI116103 · DOI
- Large, 1999, Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects, Journal of Lipid Research, 40, 2059, 10.1016/S0022-2275(20)32429-9 · DOI · Paper page
- Mowers, 2013, Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKε and TBK1, Elife, 2, e01119, 10.7554/eLife.01119 · DOI
- Arner, 2014, Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance, Trends in Endocrinology & Metabolism, 25, 255, 10.1016/j.tem.2014.03.002 · DOI · Paper page
- Coleman, 2011, Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling, Chemical Reviews, 111, 6359, 10.1021/cr100404w · DOI · Paper page
- Morigny, 2016, Adipocyte lipolysis and insulin resistance, Biochimie, 125, 259, 10.1016/j.biochi.2015.10.024 · DOI · Paper page
- Mottillo, 2007, Role of hormone-sensitive lipase in beta-adrenergic remodeling of white adipose tissue, American Journal of Physiology – Endocrinology and Metabolism, 293, E1188, 10.1152/ajpendo.00051.2007 · DOI
- Bartolomucci, 2006, TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity, Proceedings of the National Academy of Sciences of the United States of America, 103, 14584, 10.1073/pnas.0606102103 · DOI · Paper page
- Possenti, 2012, Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21, Biochemical Journal, 441, 511, 10.1042/BJ20111165 · doi:10.1042/bj20111165
- Cero, 2014, The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism, Structure, 22, 1744, 10.1016/j.str.2014.10.001 · doi:10.1016/j.str.2014.10.001
- Hannedouche, 2013, Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells, Journal of Biological Chemistry, 288, 27434, 10.1074/jbc.M113.497214 · DOI
- Fairbanks, 2014, The VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivity, Pain, 155, 1229, 10.1016/j.pain.2014.03.012 · DOI
- Stephens, 2012, A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function, Cell Metabolism, 16, 33, 10.1016/j.cmet.2012.05.011 · doi:10.1016/j.cmet.2012.05.011
- Fargali, 2014, The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure, FASEB Journal, 28, 2120, 10.1096/fj.13-239509 · doi:10.1096/fj.13-239509
- D'Amato, 2015, VGF peptide profiles in type 2 diabetic patients' plasma and in obese mice, PLoS One, 10, e0142333, 10.1371/journal.pone.0142333 · DOI
- Mamane, 2009, The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation, Diabetes, 58, 2006, 10.2337/db09-0323 · DOI · Paper page
- Bachman, 2002, betaAR signaling required for diet-induced thermogenesis and obesity resistance, Science, 297, 843, 10.1126/science.1073160 · DOI · Paper page
- Tschöp, 2011, A guide to analysis of mouse energy metabolism, Nature Methods, 9, 57, 10.1038/nmeth.1806 · DOI · Paper page
- Razzoli, 2015, Stress-induced activation of brown adipose tissue prevents obesity in conditions of low adaptive thermogenesis, Molecular Metabolism, 5, 19, 10.1016/j.molmet.2015.10.005 · DOI
- Pollesello, 1993, 1H NMR spectroscopic studies of lipid extracts from human fatty liver, Biochemical and Biophysical Research Communications, 14, 1217, 10.1006/bbrc.1993.1546 · DOI
- Sparling, 1989, Analysis of membrane lipids by 500 MHz 1H NMR, Analytical Biochemistry, 178, 67, 10.1016/0003-2697(89)90358-8 · DOI
- Hugli, 1977, Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin, Proceedings of the National Academy of Sciences of the United States of America, 74, 1826, 10.1073/pnas.74.5.1826 · doi:10.1073/pnas.74.5.1826
- Klos, 2013, Complement peptide C5a, C4a, and C3a receptors, Pharmacological Reviews, 65, 500, 10.1124/pr.111.005223 · DOI · Paper page
- Litosch, 1982, Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes, Molecular Pharmacology, 22, 109, 10.1016/S0026-895X(25)14977-8 · DOI
- Schimmel, 1984, Stimulation of cAMP accumulation and lipolysis in hamster adipocytes with forskolin, American Journal of Physiology, 246, C63, 10.1152/ajpcell.1984.246.1.C63 · doi:10.1152/ajpcell.1984.246.1.c63
- Tavernier, 2005, Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice, Molecular Pharmacology, 68, 793, 10.1124/mol.105.014670 · DOI
- Chen, 2013, Identification of a receptor for neuropeptide VGF and its role in neuropathic pain, Journal of Biological Chemistry, 288, 34638, 10.1074/jbc.M113.510917 · DOI
- Norgauer, 1993, Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein, European Journal of Biochemistry, 217, 289, 10.1111/j.1432-1033.1993.tb18245.x · DOI
- Severini, 2008, TLQP-21, a neuroendocrine VGF-derived peptide, prevents cerebellar granule cells death induced by serum and potassium deprivation, Journal of Neurochemistry, 104, 534, 10.1111/j.1471-4159.2007.05068.x · DOI
- Petrocchi-Passeri, 2013, Neuropeptide TLQP-21, a VGF internal fragment, modulates hormonal gene expression and secretion in GH3 cell line, Neuroendocrinology, 97, 212, 10.1159/000339855 · doi:10.1159/000339855
- Petrocchi-Passeri, 2015, The VGF-derived peptide TLQP-62 modulates insulin secretion and glucose homeostasis, Journal of Molecular Endocrinology, 54, 227, 10.1530/JME-14-0313 · doi:10.1530/jme-14-0313
- Agell, 2002, Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin, Cell Signal, 14, 649, 10.1016/S0898-6568(02)00007-4 · DOI · Paper page
- Cullen, 2002, Integration of calcium and Ras signaling, Nature Reviews Molecular Cell Biology, 3, 339, 10.1038/nrm808 · DOI · Paper page
- Chuderland, 2008, Calcium regulates ERK signaling by modulating its protein–protein interactions, Communicative & Integrative Biology, 1, 4, 10.4161/cib.1.1.6107 · DOI
- Greenberg, 2001, Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway, Journal of Biological Chemistry, 276, 45456, 10.1074/jbc.M104436200 · DOI · Paper page
- Arner, 1991, In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue, Journal of Pharmacology and Experimental Therapeutics, 259, 317, 10.1016/S0022-3565(25)20374-3 · DOI
- Guo, 1997, Regional lipolytic responses to isoproterenol in women, American Journal of Physiology, 273, E108
- Foglesong, 2016, Role of hypothalamic VGF in energy balance and metabolic adaption to environmental enrichment in mice, Endocrinology, 157, 983, 10.1210/en.2015-1627 · DOI
- Sadahiro, 2015, Role of VGF-derived carboxy-terminal peptides in energy balance and reproduction: analysis of “humanized” knockin mice expressing full-length or truncated VGF, Endocrinology, 156, 1724, 10.1210/en.2014-1826 · DOI
- Bal, 2012, Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals, Nature Medicine, 18, 1575, 10.1038/nm.2897 · DOI · Paper page
- Yoneshiro, 2013, Recruited brown adipose tissue as an antiobesity agent in humans, Journal of Clinical Investigation, 123, 3404, 10.1172/JCI67803 · DOI · Paper page
- Severini, 2009, In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions, British Journal of Pharmacology, 157, 984, 10.1111/j.1476-5381.2009.00192.x · doi:10.1111/j.1476-5381.2009.00192.x
- Petrella, 2012, TLQP-21, a VGF-derived peptide, stimulates exocrine pancreatic secretion in the rat, Peptides, 36, 133, 10.1016/j.peptides.2012.03.035 · doi:10.1016/j.peptides.2012.03.035
- Damann, 2008, TRPs in our senses, Current Biology, 18, R880, 10.1016/j.cub.2008.07.063 · DOI · Paper page
- Sukumar, 2012, Constitutively active TRPC channels of adipocytes confer a mechanism for sensing dietary fatty acids and regulating adiponectin, Circulation Research, 111, 191, 10.1161/CIRCRESAHA.112.270751 · DOI
- Ember, 1991, Designing synthetic superagonists of C3a anaphylatoxin, Biochemistry, 30, 3603, 10.1021/bi00229a003 · DOI
- Coulthard, 2015, Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth, Journal of Immunology, 194, 3542, 10.4049/jimmunol.1403068 · DOI · Paper page
- Lo, 2014, Adipsin is an adipokine that improves β cell function in diabetes, Cell, 158, 41, 10.1016/j.cell.2014.06.005 · DOI · Paper page
- Lim, 2013, C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling, FASEB Journal, 27, 822, 10.1096/fj.12-220582 · DOI · Paper page
- Hahm, 2002, VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting, Journal of Neuroscience, 22, 6929, 10.1523/JNEUROSCI.22-16-06929.2002 · DOI
- Hahm, 1999, Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance, Neuron, 23, 537, 10.1016/S0896-6273(00)80806-5 · DOI · Paper page
- Watson, 2005, VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity, Endocrinology, 146, 5151, 10.1210/en.2005-0588 · DOI
- Roy, 2008, Shift in metabolic fuel in acylation-stimulating protein-deficient mice following a high-fat diet, American Journal of Physiology – Endocrinology and Metabolism, 294, E1051, 10.1152/ajpendo.00689.2007 · DOI
- Murray, 2000, Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein, Endocrinology, 141, 1041, 10.1210/endo.141.3.7364 · doi:10.1210/endo.141.3.7364
- Markiewski, 2007, The role of complement in inflammatory diseases from behind the scenes into the spotlight, American Journal of Pathology, 171, 715, 10.2353/ajpath.2007.070166 · DOI · Paper page
- Nettesheim, 1988, Secondary structure of complement component C3a anaphylatoxin in solution as determined by NMR spectroscopy: differences between crystal and solution conformations, Proceedings of the National Academy of Sciences of the United States of America, 85, 5036, 10.1073/pnas.85.14.5036 · DOI
- White, 1992, Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue, Journal of Biological Chemistry, 267, 9210, 10.1016/S0021-9258(19)50409-4 · DOI · Paper page
- Cianflone, 2003, Critical review of acylation-stimulating protein physiology in humans and rodents, Biochimica et Biophysica Acta, 1609, 127, 10.1016/S0005-2736(02)00686-7 · DOI · Paper page
- Murray, 1999, Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity, Biochemical Journal, 342, 41, 10.1042/bj3420041 · doi:10.1042/bj3420041
- Bradley, 2005, Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes, Obesity Research, 13, 653, 10.1038/oby.2005.73 · DOI
- Giordano, 2005, Regional-dependent increase of sympathetic innervation in rat white adipose tissue during prolonged fasting, Journal of Histochemistry & Cytochemistry, 53, 679, 10.1369/jhc.4A6566.2005 · DOI
Cited by
Leptin and brain–adipose crosstalks
Caron, A., Lee, S., Elmquist, J. K., & Gautron, L. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.7 · Cited by 284
El Gaamouch, F., Audrain, M., Lin, W.-J., Beckmann, N., Jiang, C., Hariharan, S., Heeger, P. S., Schadt, E. E., Gandy, S., Ehrlich, M. E., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-0357-x · Cited by 92
Clearance kinetics of the VGF-derived neuropeptide TLQP-21
Guo, Z., Sahu, B. S., He, R., Finan, B., Cero, C., Verardi, R., Razzoli, M., Veglia, G., Di Marchi, R. D., Miles, J. M., et al. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.06.003 · Cited by 21
Self-citationPallais, J. P., Razzoli, M., Rodriguez, P., McGonigle, S., Daugherty, A., Hillman, H., Verteramo, L., Schrank, P. R., Parthiban, P., Chang, X., et al. (2026) · doi:10.64898/2026.04.18.719397 · Cited by 1
Self-citation
Metadata
- Authors
- Cero, C., Razzoli, M., Han, R., Sahu, B. S., Patricelli, J., Guo, Z., Zaidman, N. A., Miles, J. M., O'Grady, S. M., & Bartolomucci, A.
- Venue
- Molecular Metabolism
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 6
- Issue
- 1
- Pages
- 148-158
- ISSN
- 2212-8778
- Cited by
- 43
- References
- 4
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 439 d)
- Funders
- NIH/NIDDK (R01 DK102496)
- Decade of Discovery in Diabetes Grant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.